Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada
- 16 February 2018
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 38 (5) , 449-455
Abstract
Antipsychotic medication use has steadily increased in Canada, with an expansion in the profile of users and the diagnoses for which they are used. The use of antipsychotics is associated with a number of adverse effects for which routine monitoring is recommended. The objectives of this study were to determine the most common diagnoses associated with antipsychotic use in children in Alberta, Canada and the proportion who receive recommended laboratory tests for adverse effects.Keywords
This publication has 17 references indexed in Scilit:
- Quetiapine use in adults in the community: a population-based study in Alberta, CanadaBMJ Open, 2016
- Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive studyCMAJ Open, 2014
- Metabolic Monitoring in Commercially Insured Pediatric Patients Newly Initiated to Take a Second-Generation AntipsychoticJAMA Pediatrics, 2014
- What Does Risperidone Add to Parent Training and Stimulant for Severe Aggression in Child Attention-Deficit/Hyperactivity Disorder?Journal of the American Academy of Child & Adolescent Psychiatry, 2014
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in Children and Adolescents With Tourette’s DisorderThe Journal of Clinical Psychiatry, 2013
- The Pharmacoepidemiology of Antipsychotic Medications for Canadian Children and Adolescents: 2005–2009Journal of Child and Adolescent Psychopharmacology, 2011
- Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in ChildrenDrug Safety, 2011
- Metabolic Screening in Children Receiving Antipsychotic Drug TreatmentArchives of Pediatrics & Adolescent Medicine, 2010
- Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic AgentsAmerican Journal of Psychiatry, 2009
- Risperidone for autism spectrum disorderCochrane Database of Systematic Reviews, 2007